M.F. Mitwally
No ORCID on file
· 23 papers in corpus
· active 2002-2010
Study types
- article
18
- letter
3
- book-chapter
1
- review
1
Condition tags
- endometriosis
14
- infertility
5
Top journals
Frequent coauthors
article
2010
·doi:10.1586/eog.10.10
The third-generation aromatase inhibitor group includes letrozole, and anastrozole and exemestane have both been approved for suppression of estrogen in postmenopausal women with breast cancer. It seems scientifically plausible that various…
article
2009
·doi:10.1016/j.fertnstert.2009.02.047
book-chapter
2008
·doi:10.1017/cbo9780511547287.027
This chapter discusses the potential role of the new group of medications called aromatase inhibitors in assisted reproduction. When an aromatase inhibitor is applied during controlled ovarian hyperstimulation (COO), estrogen production per…
article
2008
·doi:10.1016/j.fertnstert.2008.07.1344
article
2008
·doi:10.1007/s10397-008-0433-7
article
2008
·doi:10.1016/j.fertnstert.2008.07.1343
article
2007
·doi:10.1016/j.fertnstert.2007.07.386
article
2007
·doi:10.1016/j.jmig.2007.06.002
article
2007
Journal of Minimally Invasive Gynecology
·doi:10.1016/j.jmig.2006.07.003
letter
2006
Journal of Minimally Invasive Gynecology
·doi:10.1016/j.jmig.2005.07.006
article
2005
·doi:10.1016/j.jmig.2005.07.112
article
2005
·doi:10.1016/j.jmig.2005.07.245
article
2005
·doi:10.1016/j.jmig.2005.07.244
article
2005
·doi:10.1016/j.fertnstert.2005.07.494
article
2005
·doi:10.1016/j.fertnstert.2005.07.1267
article
2005
·doi:10.1016/j.fertnstert.2005.07.1218
article
2005
·doi:10.1016/j.fertnstert.2005.07.1242
article
2004
Journal of the Society for Gynecologic Investigation
·doi:10.1016/j.jsgi.2004.03.006
article
2004
Fertility and Sterility
·doi:10.1016/j.fertnstert.2003.05.025
letter
2004
Fertility and Sterility
·doi:10.1016/j.fertnstert.2004.04.001
review
2003
Journal of Pediatric and Adolescent Gynecology
·doi:10.1016/j.jpag.2003.09.008
letter
2003
Fertility and Sterility
·doi:10.1016/s0015-0282(03)02170-8
article
2002
Menopause (New York, N.Y.)
·doi:10.1097/00042192-200207000-00004
OBJECTIVE: To examine the utility of a low-dose estrogen and pulsed progestogen hormone replacement therapy (HRT) regimen for add-back during long-term gonadotropin-releasing hormone-agonist (GnRH-agonist) therapy. DESIGN: A pilot clinical …